| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nippon Roche Research Center, Kamakura [Y. T., H. E., T. T., T. U., T. I., I. H., H. I.]; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo [T. K.]; and Osaka University, the Hospital of Microbial Diseases, Osaka [T. T.], Japan
The present study investigates a tumor model for cachectic mice. Among various murine transplantable tumors, used for assessing cytostatics, we identified colon 26 adenocarcinoma (colon 26) as capable of causing cachexia. Fifteen days after inoculation, the tumor grew to about 6% of the body weight causing substantial carcass weight loss of 3.4 g (14.5% of the carcass weight). When the tumor size was 2.7 g at 3 weeks after the inoculation, the carcass weight was 12 g less than the age-matched control. The tumor continued to grow while the mice maintained this weight, surviving for an average of 45 days. This extensive weight loss was essentially the wasting of adipose and muscle tissues. Hypoglycemia and hypercorticism occurred during the time of the weight loss. In addition, the colon 26 caused disorders of hepatic functions: the concentration of acute phase proteins in serum increased; the number of hepatic glucocorticoid-cytosol receptors decreased; and activities of hepatic catalase and drug-metabolizing enzymes decreased. On the other hand, noncachectic mice with Meth A fibrosarcoma gained weight, which was somewhat less than the control, and had neither hypoglycemia nor hypercorticism, although some mild disorders of hepatic functions were found. Mice bearing colon 26 is an appropriate model for elucidating the mechanism that causes cachexia.
1 To whom requests for reprints should be addressed.
Received 5/16/89. Accepted 12/19/89.
This article has been cited by other articles:
![]() |
C. Sciorati, T. Touvier, R. Buono, P. Pessina, S. Francois, C. Perrotta, R. Meneveri, E. Clementi, and S. Brunelli Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting J. Cell Sci., April 15, 2009; 122(8): 1119 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Al-Majid and H. Waters The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs, July 1, 2008; 10(1): 7 - 20. [Abstract] [PDF] |
||||
![]() |
Y.-J. Nai, Z.-W. Jiang, Z.-M. Wang, N. Li, and J.-S. Li Prevention of Cancer Cachexia by Pyrrolidine Dithiocarbamate (PDTC) in Colon 26 Tumor-Bearing Mice JPEN J Parenter Enteral Nutr, January 1, 2007; 31(1): 18 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schwarzkopf, D. Coletti, D. Sassoon, and G. Marazzi Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway Genes & Dev., December 15, 2006; 20(24): 3440 - 3452. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Diffee, K. Kalfas, S. Al-Majid, and D. O. McCarthy Altered expression of skeletal muscle myosin isoforms in cancer cachexia Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1376 - C1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tilignac, S. Temparis, L. Combaret, D. Taillandier, M.-N. Pouch, M. Cervek, D. M. Cardenas, T. Le Bricon, E. Debiton, S. E. Samuels, et al. Chemotherapy Inhibits Skeletal Muscle Ubiquitin-Proteasome-dependent Proteolysis Cancer Res., May 1, 2002; 62(10): 2771 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Samuels, A. L. Knowles, T. Tilignac, E. Debiton, J. C. Madelmont, and D. Attaix Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R133 - R139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Al-Majid and D. O. McCarthy Resistance Exercise Training Attenuates Wasting of the Extensor Digitorum Longus Muscle in Mice Bearing the Colon-26 Adenocarcinoma Biol Res Nurs, January 1, 2001; 2(3): 155 - 166. [Abstract] [PDF] |
||||
![]() |
S. Al-Majid and D. O. McCarthy Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise Biol Res Nurs, January 1, 2001; 2(3): 186 - 197. [Abstract] [PDF] |
||||
![]() |
S. E. Samuels, A. L. Knowles, T. Tilignac, E. Debiton, J. C. Madelmont, and D. Attaix Protein Metabolism in the Small Intestine during Cancer Cachexia and Chemotherapy in Mice Cancer Res., September 1, 2000; 60(17): 4968 - 4974. [Abstract] [Full Text] |
||||
![]() |
K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura, and K. Matsushima Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene J. Biol. Chem., January 3, 1997; 272(1): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |